caesarean sections (incidence 25%). We do not think that the apparently high rate of surgical interference bears any relation to the use of intrathecal morphine, but it is too early yet to be sure. Our next eight patients (not reported here) all delivered spontaneously, thus reducing the incidence of both forceps delivery and caesarean section to 15 " . In 1979 the incidence of forceps delivery among 1305 live births was 14-70' and the incidence of caesarean section 13 80,. The incidence of forceps delivery under epidural analgesia varies from 50%/ to 60%.
The use of intrathecal morphine in labour owes its origin to the basic work of Snyder4 and to reports on the use of intrathecal narcotics for managing various types of acute and chronic pain.' Epidural morphine has so far failed to relieve the pain of labour, perhaps because "the increased vascularity of the epidural space in pregnancy is responsible for rapid clearance of injected morphine so that effective concentrations of morphine in the cerebrospinal fluid and spinal cord are not reached." 6 We consider that the use of intrathecal morphine to treat and prevent the pain of labour deserves a controlled study. If that study confirms our results the implications for the pregnant woman, for patients undergoing many types of surgery, and for the disciplines of obstetrics, neonatology, and especially anaesthetics, might well be profound. (11-25 months) . Presenting features included arthritis in five, rashes in two, and all showed marked weight loss before other symptoms. All had normal renal function. The ANF titre was raised in all six patients when they developed symptoms; DNA antibody, however, was often normal, only later becoming appreciably raised in three. When hydrallazine was discontinued clinical features resolved rapidly in four, one required non-steroid anti-inflammatory drugs and was symptom free at six months, and one has required steroids for over 12 months.
The two groups of asymptomatic hypertensive patients did not differ in age, sex ratio, dosage of 3-adrenergic blocker, or renal function. There were three positive ANF titres in those patients not taking hydrallazine, all of low titre (1/16), whereas in the hydrallazine-treated group 22 
Neonatal systemic candidiasis treated with miconazole
Fortunately systemic candidiasis is uncommon in the newborn baby. Amphotericin B may be used only with caution because of the risks of severe side effects, particularly on the kidney. In this case study we describe our experiences with another antifungal agent, miconazole, an imidazole derivative widely used in adults but to our knowledge rarely used in the neonate.
Case report
A baby girl, birthweight 890 g, was born after 26 weeks' gestation. Between day 3 and day 11 she developed recurrent neonatal apnoea which was managed in turn by intermittent mask ventilation, continuous positive airways pressure, and intravenous aminophylline. On day 6 total parenteral nutrition was started by a central Silastic catheter introduced through a scalp vein. On day 9 the baby became unwell, and Staphylococcus epidermidis was isolated from blood culture. The Silastic catheter was removed and nasogastric feeding and flucloxacillin begun. On day 21 apnoeic episodes recurred, and she was again given parenteral nutrition. Intravenous chloramphenicol was started.
On day 16 Candida albicans was isolated from the mouth and groin and the baby was treated with oral and topical nystatin. C albicans was then isolated from blood culture taken on day 21. The minimal inhibitory concentration of miconazole for the C albicans isolates was determined by dilution tests in broth and recorded as the lowestantifungal concentrations that gave total inhibition of growth after 48 hours at 37°C. The minimum inhibitory concentration for miconazole was 25 mg/l but partial inhibitory effects were noted in vitro at much lower concentrations.
The central Silastic catheter was withdrawn, but Candida was not grown from the catheter tip. Nasojejunal feeding was begun. On day 28 an indurated area on the left thigh was seen to be discharging a large quantity of pus from which C albicans was later isolated. Chloramphenicol was discontinued, and a course of intravenous miconazole was started at a daily dose of 10 mg/kg given in two divided doses, each lasting two hours. The baby's general condition improved, and the candida abscess showed signs of resolution. A serum miconazole concentration measured within one hour of administration of 1-6 mg/l was determined by bioassay. On the fifth day of treatment, however, frequent episodes of ventricular tachycardia were noted and miconazole was discontinued.
On day 40 the baby once again became ill. There was persistent purulent discharge from the abscess on the left thigh and a similar abscess had now developed on the right thigh from which C albicans was isolated. Blood culture was sterile. Intravenous miconazole was restarted but, because the drug had an irritant effect on the veins which caused frequent venous thrombosis, oral miconazole was added, and the thigh abscesses were irrigated with the intravenous preparation of the drug. During this second course the serum concentration of miconazole was 2-8 mg/I. Intravenous miconazole was continued for six days, and the thigh abscesses were irrigated for 12 days.
Over this time the abscesses healed.
Comment
We encountered two major problems with miconazole. The first was an intermittent ventricular tachycardia. This has been reported in adults after rapid injections of a bolus (manufacturers' data), but in our baby it occurred between infusions: it is interesting that the problem did not recur during the second course of treatment. Clearly it is unwise to administer miconazole intravenously without facilities for heart-rate monitoring. The second problem was frequent superficial thrombophlebitis at the site of intravenous administration which resulted in considerable practical difficulties in giving the recommended dose of miconazole.
At the end of an intravenous infusion of a therapeutic dose of miconazole blood concentrations in most patients are between 1 and 10 mg/1.1 The concentrations of serum miconazole in our baby were in this range, and we gained a strong impression that clinical improvement was due to miconazole. With a minimum inhibitory concentration of 25 mg/l it might be argued that the improvement was coincidental. Nevertheless, it has been suggested that azole antifungal minimum inhibitory concentrations in vivo do not necessarily correlate with effective doses,2 and our experiences tend to support this notion.
Correspondence should be addressed to Dr D P Davies. Impotence in diabetic and non-diabetic hospital outpatients Although the reported incidence varies greatly, impotence is widely accepted as being more common in diabetics than the general population. Since the Kinsey Report' is the only source giving the incidence in the general population by age, we undertook a small survey of impotence in men attending a diabetic clinic compared with nondiabetic hospital outpatients.
Patients, methods, and results
We studied 83 consecutive male patients aged 15-60 years attending this clinic and 50 non-diabetic patients within the same age range attending hospital outpatient follow-up clinics in the same area. All answered a short questionnaire about their libido and potency or, if they did not have a sexual partner, whether they experienced morning erections; the non-diabetics were also asked whether, if their sexual performance was unsatisfactory, they had any condition that might cause this. We did not validate the questionnaire, and relied on the patients' own assessments of their sexual performance.
